[1] IWATSUKI M, MIMORI K, YOKOBORI T, et al. Epithelial-mesenchymal transition in cancer development and its clinical significance[J].Cancer Sci, 2010, 101(2):293-299. [2] 宋扬, 赵丽艳, 陈勇, 等. TGFβ1对胶质瘤U87细胞上皮-间质转化的诱导作用[J]. 吉林大学学报:医学版, 2016, 42(6):1087-1091. [3] KAHLERT U D, NIKKHAH G, MACIACZYK J. Epithelial-to-mesenchymal (-like) transition as a relevant molecular event in malignant gliomas[J]. Cancer Lett, 2013, 331(2):131-138. [4] LEE J K, JOO K M, LEE J, et al. Targeting the epithelial to mesenchymal transition in glioblastoma:the emerging role of MET signaling[J]. Onco Targets Ther, 2014, 7:1933-1944. [5] TANIA M, KHAN M A, FU JJ. Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer[J]. Tumour Biol, 2014, 35(8):7335-7342. [6] LARSEN J E, NATHAN V, OSBORNE J K, et al. ZEB1 drives epithelial-to-mesenchymal transition in lung cancer[J]. J Clin Invest, 2016, 126(9):3219-3235. [7] KREBS A M, MITSCHKE J, LASIERRA LOSADA M, et al. The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer[J]. Nat Cell Biol, 2017, 19(5):518-529. [8] 赵丽艳, 宋扬, 陈勇, 等. 白藜芦醇对胶质瘤U87细胞上皮-间质转化的抑制作用[J]. 吉林大学学报:医学版, 2018, 44(5):943-948. [9] ISER I C, PEREIRA M B, LENZ G, et al. The epithelial-to-mesenchymal transition-like process in glioblastoma:An updated systematic review and in silico investigation[J]. Med Res Rev, 2017, 37(2):271-313. [10] 宋扬, 赵丽艳, 李蕴潜,等. 胶质瘤细胞上皮-间质转化及靶向抑制策略的研究进展[J]. 吉林大学学报:医学版, 2017, 43(5):1064-1066. [11] CARAMEL J, LIGIER M, PUISIEUX A. Pleiotropic roles for ZEB1 in cancer[J]. Cancer Res, 2018, 78(1):30-35. [12] REN J, CHEN YT, SONG HZ, et al. Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line[J]. J Cell Biochem, 2013, 114(6):1395-1403. [13] SIEBZEHNRUBL F A, SILVER D J, TUGERTIMUR B, et al. The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance[J]. EMBO Mol Med, 2013, 5(8):1196-1212. [14] ZHANG L, ZHANG W, LI Y, et al. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans[J]. Oncogene, 2016, 35(43):5641-5652. [15] QIN Y, YU JX, ZHANG M, et al. ZEB1 promotes tumorigenesis and metastasis in hepatocellular carcinoma by regulating the expression of vimentin[J]. Mol Med Rep, 2019, 19(3):2297-2306. [16] BJÖRKLUND M, KOIVUNEN E. Gelatinase-mediated migration and invasion of cancer cells[J]. Biochim Biophys Acta, 2005, 1755(1):37-69. [17] KAUFHOLD S, BONAVIDA B. Central role of Snail1 in the regulation of EMT and resistance in cancer:a target for therapeutic intervention[J]. J Exp Clin Cancer Res, 2014, 33:62. [18] RADISKY E S, RADISKY D C. Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer[J]. J Mammary Gland Biol Neoplasia, 2010, 15(2):201-212. |